Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Toxicogenomic analysis of publicly available transcriptomic data can predict food, drugs, and chemical-induced asthma.

Hachim MY, Hachim IY, Elemam NM, Hamoudi RA.

Pharmgenomics Pers Med. 2019 Aug 26;12:181-199. doi: 10.2147/PGPM.S217535. eCollection 2019.

2.

Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells.

Muhammad JS, Jayakumar MN, Elemam NM, Venkatachalam T, Raju TK, Hamoudi RA, Maghazachi AA.

Immunotargets Ther. 2019 Oct 14;8:29-41. doi: 10.2147/ITT.S219867. eCollection 2019.

3.

Comparative metabolomics of MCF-7 breast cancer cells using different extraction solvents assessed by mass spectroscopy.

Semreen MH, Alniss HY, Grgic SR, El-Awady RA, Almehdi AH, Mousa MK, Hamoudi RA.

Sci Rep. 2019 Sep 11;9(1):13126. doi: 10.1038/s41598-019-49509-y.

4.

Correlation of securin and Ki67 in invasive breast carcinoma.

Talaat IM, Hamoudi RA, Yakout NM, Oweiss NY, Omar AM.

Histol Histopathol. 2019 Jun;34(6):697-709. doi: 10.14670/HH-18-071. Epub 2018 Dec 3.

PMID:
30506545
5.

Association Trends Between Antihypertensive Drug Therapies and Diastolic Hypotension in Emirati Patients with Type 2 Diabetes: A Single-Center Retrospective Longitudinal Study.

Mussa BM, Hamoudi RA, Abusnana SE.

Diabetes Ther. 2018 Oct;9(5):1853-1868. doi: 10.1007/s13300-018-0469-2. Epub 2018 Jul 24.

6.

Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.

Puccio I, Khan S, Butt A, Graham D, Sehgal V, Patel D, Novelli M, Lovat LB, Rodriguez-Justo M, Hamoudi RA.

Int J Exp Pathol. 2018 Feb;99(1):10-14. doi: 10.1111/iep.12260. Epub 2018 Feb 23.

7.

Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models.

Martinez de Pinillos Bayona A, Woodhams JH, Pye H, Hamoudi RA, Moore CM, MacRobert AJ.

Cancer Lett. 2017 May 1;393:68-75. doi: 10.1016/j.canlet.2017.02.018. Epub 2017 Feb 20.

8.

Saturation analysis for whole-genome bisulfite sequencing data.

Libertini E, Heath SC, Hamoudi RA, Gut M, Ziller MJ, Herrero J, Czyz A, Ruotti V, Stunnenberg HG, Frontini M, Ouwehand WH, Meissner A, Gut IG, Beck S.

Nat Biotechnol. 2016 Jul;34(7):691-693. doi: 10.1038/nbt.3524. Epub 2016 Jun 27. No abstract available.

PMID:
27347755
9.

Information recovery from low coverage whole-genome bisulfite sequencing.

Libertini E, Heath SC, Hamoudi RA, Gut M, Ziller MJ, Czyz A, Ruotti V, Stunnenberg HG, Frontini M, Ouwehand WH, Meissner A, Gut IG, Beck S.

Nat Commun. 2016 Jun 27;7:11306. doi: 10.1038/ncomms11306.

10.

Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.

McEwan C, Kamila S, Owen J, Nesbitt H, Callan B, Borden M, Nomikou N, Hamoudi RA, Taylor MA, Stride E, McHale AP, Callan JF.

Biomaterials. 2016 Feb;80:20-32. doi: 10.1016/j.biomaterials.2015.11.033. Epub 2015 Nov 26.

PMID:
26702983
11.

Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.

Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, de Castro DG, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA.

J Clin Pathol. 2015 Feb;68(2):111-8. doi: 10.1136/jclinpath-2014-202644. Epub 2014 Nov 27.

12.

An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.

Watkins AJ, Hamoudi RA, Zeng N, Yan Q, Huang Y, Liu H, Zhang J, Braggio E, Fonseca R, de Leval L, Isaacson PG, Wotherspoon A, McPhail ED, Dogan A, Du MQ.

PLoS One. 2012;7(9):e44997. doi: 10.1371/journal.pone.0044997. Epub 2012 Sep 13.

13.

A20 inactivation in ocular adnexal MALT lymphoma.

Bi Y, Zeng N, Chanudet E, Huang Y, Hamoudi RA, Liu H, Dong G, Watkins AJ, Ley SC, Zou L, Chen R, Zhu X, Du MQ.

Haematologica. 2012 Jun;97(6):926-30. doi: 10.3324/haematol.2010.036798. Epub 2011 Dec 29.

14.

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.

Yan Q, Huang Y, Watkins AJ, Kocialkowski S, Zeng N, Hamoudi RA, Isaacson PG, de Leval L, Wotherspoon A, Du MQ.

Haematologica. 2012 Apr;97(4):595-8. doi: 10.3324/haematol.2011.054080. Epub 2011 Nov 18.

15.

MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.

Mulholland S, Pearson DM, Hamoudi RA, Malley DS, Smith CM, Weaver JM, Jones DT, Kocialkowski S, Bäcklund LM, Collins VP, Ichimura K.

Int J Cancer. 2012 Sep 1;131(5):1104-13. doi: 10.1002/ijc.26499. Epub 2012 Jan 11.

16.

A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.

Malley DS, Hamoudi RA, Kocialkowski S, Pearson DM, Collins VP, Ichimura K.

Acta Neuropathol. 2011 May;121(5):651-61. doi: 10.1007/s00401-011-0803-5. Epub 2011 Feb 3.

PMID:
21287394
17.

Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM.

Science. 2011 Jan 28;331(6016):468-72. doi: 10.1126/science.1198946. Erratum in: Science. 2011 Apr 22;332(6028):421.

18.

A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.

Dong G, Chanudet E, Zeng N, Appert A, Chen YW, Au WY, Hamoudi RA, Watkins AJ, Ye H, Liu H, Gao Z, Chuang SS, Srivastava G, Du MQ.

Clin Cancer Res. 2011 Mar 15;17(6):1440-51. doi: 10.1158/1078-0432.CCR-10-1859. Epub 2011 Jan 25.

19.

Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.

Luan SL, Boulanger E, Ye H, Chanudet E, Johnson N, Hamoudi RA, Bacon CM, Liu H, Huang Y, Said J, Chu P, Clemen CS, Cesarman E, Chadburn A, Isaacson PG, Du MQ.

J Pathol. 2010 Oct;222(2):166-79. doi: 10.1002/path.2752.

PMID:
20690162
20.

Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.

Hamoudi RA, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, Chott A, Raderer M, Gong L, Wlodarska I, De Wolf-Peeters C, MacLennan KA, de Leval L, Isaacson PG, Du MQ.

Leukemia. 2010 Aug;24(8):1487-97. doi: 10.1038/leu.2010.118. Epub 2010 Jun 3.

PMID:
20520640
21.

Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.

Liu H, Brais R, Lavergne-Slove A, Jeng Q, Payne K, Ye H, Liu Z, Carreras J, Huang Y, Bacon CM, Hamoudi RA, Save V, Venkatraman L, Isaacson PG, Woodward J, Du MQ.

Gut. 2010 Apr;59(4):452-60. doi: 10.1136/gut.2009.186007. Epub 2009 Dec 8.

PMID:
19996326
22.

Prognostic relevance of DNA copy number changes in colorectal cancer.

Poulogiannis G, Ichimura K, Hamoudi RA, Luo F, Leung SY, Yuen ST, Harrison DJ, Wyllie AH, Arends MJ.

J Pathol. 2010 Feb;220(3):338-47. doi: 10.1002/path.2640.

PMID:
19911421
23.

A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.

Chanudet E, Huang Y, Ichimura K, Dong G, Hamoudi RA, Radford J, Wotherspoon AC, Isaacson PG, Ferry J, Du MQ.

Leukemia. 2010 Feb;24(2):483-7. doi: 10.1038/leu.2009.234. Epub 2009 Nov 12. No abstract available. Erratum in: Leukemia. 2010 Feb;24(2):488-9.

PMID:
19907439
24.

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

Chanudet E, Ye H, Ferry J, Bacon CM, Adam P, Müller-Hermelink HK, Radford J, Pileri SA, Ichimura K, Collins VP, Hamoudi RA, Nicholson AG, Wotherspoon AC, Isaacson PG, Du MQ.

J Pathol. 2009 Feb;217(3):420-30. doi: 10.1002/path.2466.

PMID:
19006194
25.

Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load.

Zhou Y, Attygalle AD, Chuang SS, Diss T, Ye H, Liu H, Hamoudi RA, Munson P, Bacon CM, Dogan A, Du MQ.

Br J Haematol. 2007 Jul;138(1):44-53.

PMID:
17555446
26.

TPL-2 MEK kinase is not targeted by mutation in diffuse large B cell lymphoma and myeloid leukemia.

Shirali S, Hamoudi RA, Bench A, Scott M, Ley SC, Du MQ.

Leuk Res. 2007 Nov;31(11):1604-7. Epub 2007 Feb 26. No abstract available.

PMID:
17324460
27.

Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells.

Johnson NA, Hamoudi RA, Ichimura K, Liu L, Pearson DM, Collins VP, Du MQ.

Lab Invest. 2006 Sep;86(9):968-78. Epub 2006 Jun 5.

28.

Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.

Mao X, Hamoudi RA, Talbot IC, Baudis M.

Cancer Genet Cytogenet. 2006 May;167(1):1-14.

PMID:
16682279
29.

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.

Chanudet E, Zhou Y, Bacon CM, Wotherspoon AC, Müller-Hermelink HK, Adam P, Dong HY, de Jong D, Li Y, Wei R, Gong X, Wu Q, Ranaldi R, Goteri G, Pileri SA, Ye H, Hamoudi RA, Liu H, Radford J, Du MQ.

J Pathol. 2006 Jul;209(3):344-51.

PMID:
16583361
30.

Genetic losses in breast cancer: toward an integrated molecular cytogenetic map.

Mao X, Hamoudi RA, Zhao P, Baudis M.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):141-51.

PMID:
15993270
31.

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, Chott A, Streubel B, Siebert R, Gesk S, Martin-Subero JI, Radford JA, Banerjee S, Nicholson AG, Ranaldi R, Remstein ED, Gao Z, Zheng J, Isaacson PG, Dogan A, Du MQ.

J Pathol. 2005 Feb;205(3):293-301.

PMID:
15682443
33.

Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci.

ELhamidi A, Hamoudi RA, Kocjan G, Du MQ.

Gynecol Oncol. 2004 Sep;94(3):671-9.

PMID:
15350357
34.

t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks.

Liu H, Hamoudi RA, Ye H, Ruskone-Fourmestraux A, Dogan A, Isaacson PG, Du MQ.

Br J Haematol. 2004 May;125(3):318-29.

PMID:
15086412
35.

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.

Thornton PD, Gruszka-Westwood AM, Hamoudi RA, Atkinson S, Kaczmarek P, Morilla RM, Hilditch BL, A'Hern R, Matutes E, Catovsky D.

Hematol J. 2004;5(1):47-54.

PMID:
14745430
36.

Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.

Obermann EC, Diss TC, Hamoudi RA, Munson P, Wilkins BS, Camozzi ML, Isaacson PG, Du MQ, Dogan A.

J Pathol. 2004 Feb;202(2):252-62.

PMID:
14743509
37.

High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation.

Chuang SS, Lee C, Hamoudi RA, Liu H, Lee PS, Ye H, Diss TC, Dogan A, Isaacson PG, Du MQ.

Br J Haematol. 2003 Jan;120(1):97-100.

PMID:
12492583
38.

Delineation of the minimal region of loss at 13q14 in multiple myeloma.

Elnenaei MO, Hamoudi RA, Swansbury J, Gruszka-Westwood AM, Brito-Babapulle V, Matutes E, Catovsky D.

Genes Chromosomes Cancer. 2003 Jan;36(1):99-106.

PMID:
12461754
39.

KSHV- and EBV-associated germinotropic lymphoproliferative disorder.

Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabeçadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG.

Blood. 2002 Nov 1;100(9):3415-8.

PMID:
12384445
40.

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ.

Gastroenterology. 2002 May;122(5):1286-94.

PMID:
11984515
41.

Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene.

Gruszka-Westwood AM, Atkinson S, Summersgill BM, Shipley J, Elnenaei MO, Jain P, Hamoudi RA, Kaeda JS, Wotherspoon AC, Matutes E, Catovsky D.

Genes Chromosomes Cancer. 2002 Feb;33(2):206-12.

PMID:
11793447
42.

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators.

Br J Cancer. 2001 Nov 2;85(9):1383-6.

43.

T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.

Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ.

Blood. 2001 Aug 15;98(4):1182-7.

PMID:
11493468
44.

p53 abnormalities in splenic lymphoma with villous lymphocytes.

Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D.

Blood. 2001 Jun 1;97(11):3552-8.

PMID:
11369650
45.

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG.

Blood. 2001 Apr 1;97(7):2130-6. Erratum in: Blood 2001 Jun 1;97(11):3678.

PMID:
11264181
46.

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.

Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG.

Lancet. 2001 Jan 6;357(9249):39-40.

PMID:
11197361
47.

Molecular and cytogenetic analysis of glioblastoma multiforme.

Mao X, Hamoudi RA.

Cancer Genet Cytogenet. 2000 Oct 15;122(2):87-92.

PMID:
11106817
48.
49.

BCL10 gene mutation in lymphoma.

Du MQ, Peng H, Liu H, Hamoudi RA, Diss TC, Willis TG, Ye H, Dogan A, Wotherspoon AC, Dyer MJ, Isaacson PG.

Blood. 2000 Jun 15;95(12):3885-90.

PMID:
10845924
50.

No evidence of germline PTEN mutations in familial prostate cancer.

Forrest MS, Edwards SM, Hamoudi RA, Dearnaley DP, Arden-Jones A, Dowe A, Murkin A, Kelly J, Teare MD, Easton DF, Knowles MA, Bishop DT, Eeles RA.

J Med Genet. 2000 Mar;37(3):210-2. No abstract available.

Supplemental Content

Loading ...
Support Center